First carbapenem-resistant isolates of Acinetobacter soli in Japan

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2786-2787

  Endo, Shiro ^a   Sasano, Mina ^a   Yano, Hisakazu ^a   Arai, Kazuaki ^a   Aoyagi, Tetsuji ^a   Hatta, Masumitsu ^a   Gu, Yoshiaki ^a   Yamada, Mitsuhiro ^a   Tokuda, Koichi ^a   Ogawa, Miho ^b   Shimojima, Masahiro ^b   Kitagawa, Miho ^a   Kunishima, Hiroyuki ^a   Hirakata, Yoichi ^a   Kaku, Mitsuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kawagoe shi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; COLISTIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NALIDIXIC ACID; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; BLOOD CULTURE; HUMAN; JAPAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA;

EID: 84860112236     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00021-12     Document Type: Letter

References (11)

1. Bratu S, Landman D, Martin DA, Georgescu C, Quale J. 2008. Correlation of antimicrobial resistance with β-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob. Agents Chemother. 52:2999-3005.
2. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; standard - eighth edition. CLSI M07-A8. Clinical and Laboratory Standards Institute. Wayne, PA.
3. Espinal P, et al. 2011. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55:5396-5398.
4. Espinal P, Roca I, Vila J. 2011. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future Microbiol. 6:495-511.
5. Karah N, et al. 2011. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J. Antimicrob. Chemother. 66:738-744.
6. Kim D, et al. 2008. Acinetobacter soli sp. nov., isolated from forest soil. J. Microbiol. 46:396-401.
7. La Scola B, Gundi VA, Khamis A, Raoult D. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44:827-832.
8. Pellegrino FL, et al. 2011. Acinetobacter soli as a cause of bloodstream infection in a neonatal intensive care unit. J. Clin. Microbiol. 49:2283-2285.
9. OXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:1442-1448.
10. Villalón P, et al. 2011. Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J. Clin. Microbiol. 49:875-882.
11. Yum JH, et al. 2002. Molecular characterization of metallo-β- lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J. Antimicrob. Chemother. 49:837-840. (Pubitemid 34537647)